Scientists Found 2 Existing Drugs Could Reverse Alzheimer's Brain Damage in Mice
Researchers discovered that two existing cancer drugs, letrozole and irinotecan, may reverse Alzheimer's-related brain damage in mice by reducing harmful tau protein buildup and improving cognitive function. The drugs were identified through computational analysis of gene expression changes linked to Alzheimer's and tested in mouse models, showing promising results in targeting different brain cells affected by the disease. The findings suggest these FDA-approved medications could be repurposed for Alzheimer's treatment, potentially accelerating clinical trials and offering new therapeutic approaches.
Scientists found that two existing cancer drugs, letrozole and irinotecan, reversed Alzheimer's-related brain damage in mice.
These drugs, already approved for cancer, could speed up Alzheimer's treatment research by skipping early development stages.
This discovery offers hope for repurposing safe, existing medications to tackle a growing global health challenge with personalized approaches.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.